This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's Why You Should Stay Away From Anthem (ANTM) Right Now
by Zacks Equity Research
Anthem's (ANTM) weak balance sheet and steep expenses will likely keep the stock stressed.
Here's Why Hold Strategy is Apt for Centene (CNC) Stock
by Zacks Equity Research
Riding on its inorganic growth story and 2021 guidance, Centene (CNC) holds enough potential to reap benefits for investors.
Select Medical (SEM) Up 29.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Select Medical (SEM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
6 Reasons Why Select Medical (SEM) Stock Looks Attractive
by Zacks Equity Research
Select Medical's (SEM) prolific lines of business, top-line growth, proven financial performance and strong cash flow, inorganic growth profile, partnerships with healthcare system giants bode well.
Centene (CNC) to Aid Eligible Medicaid Members in Hawaii
by Zacks Equity Research
Centene's (CNC) new agreement intends to improve health outcomes for eligible Medicaid and CHIP members of Hawaii.
Here's How Much a $1000 Investment in Select Medical Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Can Select Medical (SEM) Stock Continue to Grow Earnings?
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Select Medical (SEM).
Anthem (ANTM) to Buy myNEXUS to Boost Homehealth Business
by Zacks Equity Research
Anthem (ANTM) to purchase at-home provider, benefits coordinator, myNEXUS, to provide better in-home care.
Top Ranked Momentum Stocks to Buy for March 24th
by Zacks Equity Research
CPE, ZEUS, RBNC, and SEM made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 24, 2021
Top Ranked Growth Stocks to Buy for March 24th
by Zacks Equity Research
HIBB, HRI, UEIC and SEM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 24, 2021
Select Medical (SEM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Select Medical (SEM) closed the most recent trading day at $34.68, moving -1.14% from the previous trading session.
Encompass Health (EHC) Set to Boost South Carolina Footprint
by Zacks Equity Research
Encompass Health (EHC) introduced plans to construct a hospital in South Carolina for offering enhanced rehabilitative care across the state.
If You Invested $1000 in Select Medical 10 Years Ago, This Is How Much You'd Have Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Zacks.com featured highlights include: Matson, Piper Sandler, Century Communities, L.B. Foster and Select Medical Holdings
by Zacks Equity Research
Zacks.com featured highlights include: Matson, Piper Sandler, Century Communities, L.B. Foster and Select Medical Holdings
Zacks.com featured highlights include: Select Medical Holdings, Veritiv Corp, Century Communities, Matson and Piper Sandler Companies
by Zacks Equity Research
Zacks.com featured highlights include: Select Medical Holdings, Veritiv Corp, Century Communities, Matson and Piper Sandler Companies
5 Stocks With Increasing Cash Flows to Enrich Your Portfolio
by Moumita C. Chattopadhyay
Looking beyond profits to a company's cash position will be far more rewarding as this highlights its true financial health.
6 Buy-Ranked Stocks With Impressive Net Profit Margins
by Anirudha Bhagat
Let's take a look at the six top-ranked stocks with impressive net profit margins for an enriching portfolio.
Is Select Medical Holdings (SEM) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (SEM) Outperforming Other Medical Stocks This Year?
Here's How Much a $1000 Investment in Select Medical Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Select Medical (SEM) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Select Medical (SEM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Select Medical (SEM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Select Medical (SEM) closed at $35.15 in the latest trading session, marking a -0.37% move from the prior day.
Tenet Healthcare (THC) Hits 52 Week High: Will the Rally Stay?
by Zacks Equity Research
Tenet Healthcare's (THC) shares display an upsurge as investors get optimistic about its latest strategic initiatives and cost-curbing measures.
Are Investors Undervaluing Select Medical (SEM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina Healthcare (MOH) Up 86% in a Year: More Room to Run?
by Zacks Equity Research
Molina Healthcare (MOH) is well-poised to gain from a robust Medicare and Medicaid business, and numerous buyouts for boosting its service offerings.
Zacks.com featured highlights include: Veritiv Corp, Danaos Corp, Select Medical Holdings, EnPro Industries and ArcelorMittal
by Zacks Equity Research
Zacks.com featured highlights include: Veritiv Corp, Danaos Corp, Select Medical Holdings, EnPro Industries and ArcelorMittal